Medical News

A Novel Risk-Predicted Nomogram for Sepsis Associated-Acute...
BMC Nephrol.

This study developed and validated an AKI risk prediction nomogram applied to critically ill patients with sepsis,...

12 May 2021

Higher 1-Year Mortality in Women Admitted to Intensive Care...
J Crit Care.

Women admitted to the ICU after cardiac arrest have a higher mortality rate than men. After left-truncation, we...

06 May 2021

Intra-Abdominal Hypertension and Hypoxic Respiratory Failure...
J Crit Care.

In our sub-analysis, the combination of IAH and HRF was not independently associated with 90-day mortality but...

28 Apr 2021

Towards Understanding the Effective Use of Antibiotics for S...
Chest.

An interaction between age and benefits of early antibiotics for sepsis has not been reported before. When...

26 Apr 2021

Key Trials

Pharmacokinetics and Pharmacodynamics of Imipenem by Two-Step and Extended Infusions in Sepsis Patients

The pharmacokinetic/pharmacodynamic (PK/PD) parameters achieved in two-step and extended regimens of imipenem were comparable in the treatment of...

Benefits of Inhaled Budesonide in Early COVID-19 Infection: STOIC Study

This infographic summarises the key points of the STOIC study and outlines the benefits of administering inhaled budesonide in early COVID-19...

Utility of C-Reactive Protein Based Protocol in the Duration of Antibiotic Therapy in Critically Ill Patients

A protocol based on daily monitoring of C-reactive protein levels may allow early interruption of antibiotic therapy in a higher proportion of...

Novel Antibiotic Adjuvant Entity Might Be an Effective Empirical Therapy for Treating Nosocomial Infections

It can be concluded that the use of CSE 1034 of ceftriaxone, sulbactam, and ethylenediaminetetraacetic acid is an effective option for the treatment...

Slide Library

Cefuroxime (Novacef)

Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....

 
Email this page
Management of Mucormycosis in ENT Practice

Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...

 
Email this page
Antifungal Therapy in Immunocompromised Patients

Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...

 
Email this page
Disseminated Tuberculosis with ARDS

Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...

 
Email this page

Our Publications

Cytorx (Flucytosine) Monograph

This monograph describes the role of Flucytosine tablets in the management of invasive cryptococcal infections and some Candida spp. infections.  

Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections

Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...

MRSA: The Clinician’s Challenge

The article summarizes the Indian epidemiological data for MRSA infections, along with treatment of MRSA infections and infection control measures.

Phosome IV (Liposomal Amphotericin B) Monograph

Amphotericin B deoxycholate has a broad antifungal activity, and today it is the best antifungal available against most systemic fungal infections,...